List of Tables
Table 1. Global Buspirone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 5mg
Table 3. Major Manufacturers of 10mg
Table 4. Major Manufacturers of 15mg
Table 5. Major Manufacturers of 30mg
Table 6. Global Buspirone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Buspirone Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Buspirone Sales by Region (2017-2022) & (K Units)
Table 9. Global Buspirone Sales Market Share by Region (2017-2022)
Table 10. Global Buspirone Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Buspirone Revenue Market Share by Region (2017-2022)
Table 12. Global Buspirone Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Buspirone Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Buspirone Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Buspirone Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Buspirone Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Buspirone Market Trends
Table 18. Buspirone Market Drivers
Table 19. Buspirone Market Challenges
Table 20. Buspirone Market Restraints
Table 21. Global Buspirone Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Buspirone Sales Share by Manufacturers (2017-2022)
Table 23. Global Buspirone Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Buspirone Manufacturers by Revenue (US$ Million) in 2021
Table 25. Buspirone Revenue Share by Manufacturers (2017-2022)
Table 26. Global Buspirone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Buspirone as of 2021)
Table 28. Key Manufacturers Buspirone Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 29. Key Manufacturers Buspirone Plants/Factories Distribution
Table 30. Key Manufacturers Buspirone Area Served
Table 31. Date of Key Manufacturers Enter into Buspirone Market
Table 32. Key Manufacturers Buspirone Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Buspirone Sales (K Units) by Type (2017-2022)
Table 35. Global Buspirone Sales Share by Type (2017-2022)
Table 36. Global Buspirone Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Buspirone Price (K Units) by Type (2017-2022)
Table 38. Global Buspirone Sales (K Units) by Type (2023-2028)
Table 39. Global Buspirone Sales Share by Type (2023-2028)
Table 40. Global Buspirone Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Buspirone Revenue Share by Type (2023-2028)
Table 42. Global Buspirone Price (K Units) by Type (2023-2028)
Table 43. Global Buspirone Sales (K Units) by Application (2017-2022)
Table 44. Global Buspirone Sales Share by Application (2017-2022)
Table 45. Global Buspirone Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Buspirone Price (K Units) by Application (2017-2022)
Table 47. Global Buspirone Sales (K Units) by Application (2023-2028)
Table 48. Global Buspirone Sales Share by Application (2023-2028)
Table 49. Global Buspirone Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Buspirone Revenue Share by Application (2023-2028)
Table 51. Global Buspirone Price (K Units) by Application (2023-2028)
Table 52. North America Buspirone Sales by Company (2017-2022) & (K Units)
Table 53. North America Buspirone Sales Market Share by Company (2017-2022)
Table 54. North America Buspirone Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Buspirone Revenue Market Share by Company (2017-2022)
Table 56. North America Buspirone Sales by Type (2017-2022) & (K Units)
Table 57. North America Buspirone Sales by Type (2023-2028) & (K Units)
Table 58. North America Buspirone Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Buspirone Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Buspirone Sales by Application (2017-2022) & (K Units)
Table 61. North America Buspirone Sales by Application (2023-2028) & (K Units)
Table 62. North America Buspirone Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Buspirone Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Buspirone Sales by Country (2017-2022) & (K Units)
Table 65. North America Buspirone Sales by Country (2023-2028) & (K Units)
Table 66. North America Buspirone Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Buspirone Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Buspirone Sales by Company (2017-2022) & (K Units)
Table 69. Europe Buspirone Sales Market Share by Company (2017-2022)
Table 70. Europe Buspirone Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Buspirone Revenue Market Share by Company (2017-2022)
Table 72. Europe Buspirone Sales by Type (2017-2022) & (K Units)
Table 73. Europe Buspirone Sales by Type (2023-2028) & (K Units)
Table 74. Europe Buspirone Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Buspirone Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Buspirone Sales by Application (2017-2022) & (K Units)
Table 77. Europe Buspirone Sales by Application (2023-2028) & (K Units)
Table 78. Europe Buspirone Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Buspirone Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Buspirone Sales by Country (2017-2022) & (K Units)
Table 81. Europe Buspirone Sales by Country (2023-2028) & (K Units)
Table 82. Europe Buspirone Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Buspirone Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Buspirone Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Buspirone Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Buspirone Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Buspirone Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Buspirone Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Buspirone Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Buspirone Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Buspirone Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Buspirone Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Buspirone Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Buspirone Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Buspirone Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Buspirone Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Buspirone Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Buspirone Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Buspirone Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Buspirone Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Buspirone Sales Market Share by Company (2017-2022)
Table 102. Latin America Buspirone Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Buspirone Revenue Market Share by Company (2017-2022)
Table 104. Latin America Buspirone Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Buspirone Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Buspirone Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Buspirone Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Buspirone Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Buspirone Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Buspirone Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Buspirone Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Buspirone Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Buspirone Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Buspirone Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Buspirone Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Buspirone Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Buspirone Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Buspirone Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Buspirone Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Buspirone Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Buspirone Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Buspirone Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Buspirone Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Buspirone Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Buspirone Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Buspirone Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Buspirone Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Buspirone Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Buspirone Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Buspirone Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Buspirone Revenue by Country (2023-2028) & (US$ Million)
Table 132. Bristol Myers Squibb Corporation Information
Table 133. Bristol Myers Squibb Description and Overview
Table 134. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 135. Bristol Myers Squibb Buspirone Product and Services
Table 136. Bristol Myers Squibb Buspirone SWOT Analysis
Table 137. Bristol Myers Squibb Recent Developments
Table 138. Apotex Corporation Information
Table 139. Apotex Description and Overview
Table 140. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 141. Apotex Buspirone Product and Services
Table 142. Apotex Buspirone SWOT Analysis
Table 143. Apotex Recent Developments
Table 144. Dr. Reddy's Laboratories Corporation Information
Table 145. Dr. Reddy's Laboratories Description and Overview
Table 146. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 147. Dr. Reddy's Laboratories Buspirone Product and Services
Table 148. Dr. Reddy's Laboratories Buspirone SWOT Analysis
Table 149. Dr. Reddy's Laboratories Recent Developments
Table 150. Laboratoires Servier Corporation Information
Table 151. Laboratoires Servier Description and Overview
Table 152. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 153. Laboratoires Servier Buspirone Product and Services
Table 154. Laboratoires Servier Buspirone SWOT Analysis
Table 155. Laboratoires Servier Recent Developments
Table 156. Teva Corporation Information
Table 157. Teva Description and Overview
Table 158. Teva Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 159. Teva Buspirone Product and Services
Table 160. Teva Buspirone SWOT Analysis
Table 161. Teva Recent Developments
Table 162. AMAG Pharmaceuticals Corporation Information
Table 163. AMAG Pharmaceuticals Description and Overview
Table 164. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 165. AMAG Pharmaceuticals Buspirone Product and Services
Table 166. AMAG Pharmaceuticals Buspirone SWOT Analysis
Table 167. AMAG Pharmaceuticals Recent Developments
Table 168. Mylan Corporation Information
Table 169. Mylan Description and Overview
Table 170. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 171. Mylan Buspirone Product and Services
Table 172. Mylan Buspirone SWOT Analysis
Table 173. Mylan Recent Developments
Table 174. Novartis Corporation Information
Table 175. Novartis Description and Overview
Table 176. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 177. Novartis Buspirone Product and Services
Table 178. Novartis Buspirone SWOT Analysis
Table 179. Novartis Recent Developments
Table 180. Watson Laboratories Corporation Information
Table 181. Watson Laboratories Description and Overview
Table 182. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 183. Watson Laboratories Buspirone Product and Services
Table 184. Watson Laboratories Buspirone SWOT Analysis
Table 185. Watson Laboratories Recent Developments
Table 186. Hikma Corporation Information
Table 187. Hikma Description and Overview
Table 188. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 189. Hikma Buspirone Product and Services
Table 190. Hikma Buspirone SWOT Analysis
Table 191. Hikma Recent Developments
Table 192. Wockhardt Corporation Information
Table 193. Wockhardt Description and Overview
Table 194. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 195. Wockhardt Buspirone Product and Services
Table 196. Wockhardt Recent Developments
Table 197. Cadila Healthcare Corporation Information
Table 198. Cadila Healthcare Description and Overview
Table 199. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 200. Cadila Healthcare Buspirone Product and Services
Table 201. Cadila Healthcare Recent Developments
Table 202. Orion Corporation Corporation Information
Table 203. Orion Corporation Description and Overview
Table 204. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 205. Orion Corporation Buspirone Product and Services
Table 206. Orion Corporation Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Buspirone Distributors List
Table 210. Buspirone Customers List
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Buspirone Product Picture
Figure 2. Global Buspirone Sales Market Share by Type in 2021 & 2028
Figure 3. 5mg Product Picture
Figure 4. 10mg Product Picture
Figure 5. 15mg Product Picture
Figure 6. 30mg Product Picture
Figure 7. Global Buspirone Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Use Case
Figure 9. Drug Store Use Case
Figure 10. Buspirone Report Years Considered
Figure 11. Global Buspirone Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Buspirone Market Size 2017-2028 (US$ Million)
Figure 13. Global Buspirone Sales (2017-2022) & (K Units)
Figure 14. Global Buspirone Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Buspirone Sales Market Share by Region (2017-2022)
Figure 16. Global Buspirone Sales Market Share by Region in 2021
Figure 17. Global Buspirone Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Buspirone Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Buspirone Sales in 2021
Figure 20. Buspirone Revenue Share by Manufacturers in 2021
Figure 21. Buspirone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Buspirone Revenue Share by Type (2017-2022)
Figure 23. Global Buspirone Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Buspirone Revenue Share by Application (2017-2022)
Figure 25. Global Buspirone Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Buspirone Sales Market Share by Type (2017-2028)
Figure 27. North America Buspirone Revenue Market Share by Type (2017-2028)
Figure 28. North America Buspirone Sales Market Share by Application (2017-2028)
Figure 29. North America Buspirone Revenue Market Share by Application (2017-2028)
Figure 30. North America Buspirone Sales Share by Country (2017-2028)
Figure 31. North America Buspirone Revenue Share by Country (2017-2028)
Figure 32. United States Buspirone Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Buspirone Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Buspirone Sales Market Share by Type (2017-2028)
Figure 35. Europe Buspirone Revenue Market Share by Type (2017-2028)
Figure 36. Europe Buspirone Sales Market Share by Application (2017-2028)
Figure 37. Europe Buspirone Revenue Market Share by Application (2017-2028)
Figure 38. Europe Buspirone Sales Share by Country (2017-2028)
Figure 39. Europe Buspirone Revenue Share by Country (2017-2028)
Figure 40. Germany Buspirone Revenue (2017-2028) & (US$ Million)
Figure 41. France Buspirone Revenue (2017-2028) & (US$ Million)
Figure 42. U.K. Buspirone Revenue (2017-2028) & (US$ Million)
Figure 43. Italy Buspirone Revenue (2017-2028) & (US$ Million)
Figure 44. Russia Buspirone Revenue (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Buspirone Sales Market Share by Type (2017-2028)
Figure 46. Asia Pacific Buspirone Revenue Market Share by Type (2017-2028)
Figure 47. Asia Pacific Buspirone Sales Market Share by Application (2017-2028)
Figure 48. Asia Pacific Buspirone Revenue Market Share by Application (2017-2028)
Figure 49. Asia Pacific Buspirone Sales Share by Region (2017-2028)
Figure 50. Asia Pacific Buspirone Revenue Share by Region (2017-2028)
Figure 51. China Buspirone Revenue (2017-2028) & (US$ Million)
Figure 52. Japan Buspirone Revenue (2017-2028) & (US$ Million)
Figure 53. South Korea Buspirone Revenue (2017-2028) & (US$ Million)
Figure 54. India Buspirone Revenue (2017-2028) & (US$ Million)
Figure 55. Australia Buspirone Revenue (2017-2028) & (US$ Million)
Figure 56. China Taiwan Buspirone Revenue (2017-2028) & (US$ Million)
Figure 57. Indonesia Buspirone Revenue (2017-2028) & (US$ Million)
Figure 58. Thailand Buspirone Revenue (2017-2028) & (US$ Million)
Figure 59. Malaysia Buspirone Revenue (2017-2028) & (US$ Million)
Figure 60. Latin America Buspirone Sales Market Share by Type (2017-2028)
Figure 61. Latin America Buspirone Revenue Market Share by Type (2017-2028)
Figure 62. Latin America Buspirone Sales Market Share by Application (2017-2028)
Figure 63. Latin America Buspirone Revenue Market Share by Application (2017-2028)
Figure 64. Latin America Buspirone Sales Share by Country (2017-2028)
Figure 65. Latin America Buspirone Revenue Share by Country (2017-2028)
Figure 66. Mexico Buspirone Revenue (2017-2028) & (US$ Million)
Figure 67. Brazil Buspirone Revenue (2017-2028) & (US$ Million)
Figure 68. Argentina Buspirone Revenue (2017-2028) & (US$ Million)
Figure 69. Middle East and Africa Buspirone Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Buspirone Revenue Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Buspirone Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Buspirone Revenue Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Buspirone Sales Share by Country (2017-2028)
Figure 74. Middle East and Africa Buspirone Revenue Share by Country (2017-2028)
Figure 75. Turkey Buspirone Revenue (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Buspirone Revenue (2017-2028) & (US$ Million)
Figure 77. UAE Buspirone Revenue (2017-2028) & (US$ Million)
Figure 78. Buspirone Value Chain
Figure 79. Buspirone Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed